Great Point Partners
Great Point Partners is a healthcare investment firm focused on growing companies across the biopharmaceutical supply chain, healthcare IT-enabled services, healthcare services, and medical-device manufacturing.
- Healthcare and life sciences private equity investment firm
- Healthcare & Life Sciences PEF
- Tier III
Overview
Great Point Partners is a healthcare investment firm focused on growing companies across the biopharmaceutical supply chain, healthcare IT-enabled services, healthcare services, and medical-device manufacturing.
The firm targets profitable or commercially established businesses operating in specialized markets where customer relationships, regulatory standards, technical expertise, and management quality are essential. These characteristics are common in outsourced life sciences and healthcare infrastructure. Within The Economy Wiki, the firm is connected to the Healthcare & Life Sciences PEF market category.
Firm facts
| Institution | Great Point Partners |
| Type | Healthcare and life sciences private equity investment firm |
| Headquarters | Greenwich, United States |
| Founded | 2003 |
| Primary ranking focus | Healthcare & Life Sciences PEF |
| Highest 2026 tier | Tier III |
Activities and investment capabilities
Great Point combines private equity with sector research and operational support. Its mandate allows it to invest across service, technology, and product-related businesses while maintaining a consistent healthcare focus.
Healthcare investing
Equity investment across healthcare services, products and technology.
Life sciences exposure
Capital for pharmaceutical, biotechnology, medtech and outsourced-service platforms.
Sector value creation
Support informed by regulation, reimbursement, clinical workflows and market access.
Strategy and transaction coverage
Strategy and sector coverage
Healthcare services; life sciences; pharmaceuticals; medtech; diagnostics; healthcare IT
Transaction and ownership contexts
Buyouts; growth investments; recapitalizations; platform formation; add-on acquisitions
Market position
Great Point Partners fits Tier III because it is an active and credible specialist with particular strength in life sciences-adjacent services and lower-middle-market healthcare growth.
Great Point Partners is assessed within the Healthcare & Life Sciences PEF framework. For wider market context, see The Mid-Market Advantage in Healthcare Private Equity.
Competitive context
Great Point Partners is recognized Tier III in Top 30 Healthcare & Life Sciences PEF 2026. The ranking compares firms by institutional relevance, specialist capability, investment activity, operating depth and market positioning. Comparable-firm links below support navigation and do not imply that every institution competes for every transaction or asset.
Leadership and governance
Leadership, investment-committee composition and operating resources may change over time. Current information should be confirmed through Great Point Partners’s official website.
| Leadership area | Current source |
|---|---|
| Investment and operating leadership | Current team and governance information |
Corporate and public information
This profile refers to Great Point Partners as the public-facing investment organization. Individual funds, management companies, advisers and regulated entities may use separate legal names across jurisdictions.
Corporate and disclosure information
| Organization | Great Point Partners |
| Headquarters | Greenwich, United States |
| Public website | www.gppfunds.com |
| Profile basis | Public institutional information and Capital Ranking editorial research |
Ranking recognition
Related Economy analysis
Selected Economy Markets articles provide context for the investment, diligence, financing and value-creation themes relevant to this firm:
- The Mid-Market Advantage in Healthcare Private Equity
- Middle-Market Private Equity: Returns, Scale and Manager Selection
- Private Equity Technology Due Diligence in the AI Era
